Monday, September 14, 2026

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

2026 Residency Report: Why Reduced Working Hours Aren’t Improving Mental Health for Asian Doctors

Despite reduced working hours, medical residents face worsening mental health, highlighting a need for better training and support systems.

AI-Powered Warfare: US Military Used Maven Smart System in Iran Airstrikes Report

The U.S. and Israel's airstrikes against Iran were enhanced by AI systems, enabling rapid target analysis and operational efficiency.

Tag: genorosity

No posts to display

Top News

- Our Sponsors Ad -

Follow us